Synthesis of New 2-Substituted 6-Bromo-3-methylthiazolo[3,2-a]-benzimidazole Derivatives and their Biological Activities

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 66, Issue 1-2, 2011, Pages 7-16

  Abdel Aziza, Hatem A ^a   Hamdya, Nehal A ^a   Gamal Eldeenb, Amira M ^a   Fakhra, Issa M I ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Anti Infl ammatory; Anticancer; Thiazolo 3,2 a benzimidazole

Indexed keywords

BENZIMIDAZOLE DERIVATIVE;

ARTICLE; CHEMISTRY; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL LINE; X RAY CRYSTALLOGRAPHY;

BENZIMIDAZOLES; CELL LINE, TUMOR; CRYSTALLOGRAPHY, X-RAY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79953046892     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2011-1-202     Document Type: Article

References (23)

1. Abdel-Aziz H. A., Hamdy N. A., Farag A. M., and Fakhr I. M. I. (2008), Synthesis of some novel pyrazolo[1, 5-a]pyrimidine, 1, 2, 4-triazolo[1, 5-a]pyrimidine, pyrido[2, 3-d]pyrimidine, pyrazolo[5, 1-c]-1, 2, 4-triazine and 1, 2, 4-triazolo[5, 1-c]-1, 2, 4-triazine derivatives incorporating a thiazolo[3, 2-a]benzimidazole moiety. J. Heterocycl. Chem. 45, 1-5.
2. Adams R. and Dix J. S. (1958), The reaction of 2-ami-nopyridine with a-halo ketones. J. Am. Chem. Soc. 80, 4618-4620.
3. Altomare A., Cascarano G., Giacovazzo C., Guagliardi A., Burla M. C., Polidori G., and Camalli M. (1994), Program for automatic solution of crystal structures by direct methods optimized for powder data. J. Appl. Cryst. 27, 435-436.
4. Anandan S., Ward J. S., Brokx R. D., Denny T., Bray M. R., Patel D. V., and Xiao X. (2007), Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors. Bioorg. Med. Chem. Lett. 17, 5995-5999.
5. DʼnAmico J. J., Campbell R. H., and Guinn E. C. (1964), Derivatives of 3-methylthiazolo[3, 2-a]benzimidazole. J. Org. Chem. 29, 865-869.
6. Dawood K. M., Farag A. M., and Abdel-Aziz H. A. (2005), Azoles and azolo-azines via 3-(3-methylbenzofuran-2-yl)-3-oxopropanenitrile. J. Chem. Res., 378-381.
7. Dawood K. M., Farag A. M., and Abdel-Aziz H. A. (2007), Synthesis of some new benzofuran-based thiophene, 1, 3-oxathiole and 1, 3, 4-oxa (thia) diazole derivatives. Heteroatom Chem. 18, 294-300.
8. Dillman R. O., Ryan K. P., Dillman J. B., Shawler D. L., and Maguire R. (1992), Phase I cancer trials: limitations and implications. Mol. Biother. 4, 10-14.
9. Eickhoff W. M., Engers D. A., and Mueller K. R. (1996), Nanoparticulate nsaid compositions. U. S. patent 96, 24, 336.
10. Fukunaga I., Yeo C. H., and Batchelor A. M. (2007), Potent and specific action of the mGlu1 antagonists YM-298198 and JNJ16259685 on synaptic transmission in rat cerebellar slices. Br. J. Pharmacol. 151, 870-876.
11. Gerhauser C., Klimo K., Heiss E., Neumann I., Gamal-Eldeen A., Knauft J., Liu J.-U., Sitthimonchai S., and Frank N. (2003), Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat. Res. 523-524, 163-172.
12. Gilman S. C., Carlson R. P., Daniels J. F., Datko L., Berner P. R., Chang J., and Lewis A. J., (1987), Im-munological abnormalities in rats with adjuvant-induced arthritis-II. Effect of antiarthritic therapy on immune function in relation to disease development. Int. J. Immunopharmacol. 9, 9-16.
13. Girotti M., Evans J. H., Burke D., and Leslie C. C. (2004), Cytosolic phospholipase A2 translocates to forming phagosomes during phagocytosis of zymosan in macrophages. J. Biol. Chem. 279, 19113-19121.
14. Hamdy N. A., Abdel-Aziz H. A., Farag A. M., and Fakhr I. M. I. (2007), Synthesis of some 1, 3-thiazole, 1. 3. 4-thiadiazole, pyrazolo[5, 1-c]-1, 2, 4-triazine, and 1. 2. 4-triazolo[5, 1-c]-1, 2, 4-triazine derivatives based on the thiazolo[3, 2-a]benzimidazole moiety. Monatsh. Chem. 138, 1001-1010.
15. Hansen M. B., Nielsen S. E., and Berg K. (1989), Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119, 203-210.
16. Hu L., Gunn C., and Beckman J. (1992), Bactericidal activity of peroxynitrite. Arch. Biochem. Biophys. 298, 452-457.
17. Ismaila M. A., Arafa R. K., Wenzler T., Brun R., Tani-ous F. A., Wilson W. D., and Boykin D. W. (2008), Synthesis and antiprotozoal activity of novel bis-benzamidino imidazo[1, 2-a]pyridines and 5, 6, 7, 8-tet-rahydro-imidazo[1, 2-a]pyridines. Bioorg. Med. Chem. 16, 683-691.
18. Kohara A., Toya T., Tamura S., Watabiki T., Nagakura Y., Shitaka Y., Hayashibe S., Kawabata S., and Okada M. (2005), Radioligand binding properties and pharmacological characterization of 6-amino-N-cy-clohexyl-N, 3-dimethylthiazolo[3, 2-a]benzimidazole-2-carboxamide (YM-298198), a high-affinity, selective, and noncompetitive antagonist of metabotropic glutamate receptor type 1. J. Pharmacol. Exp. Ther. 315, 163-169.
19. MacMicking J., Xie Q. W., and Nathan C. (1997), Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350.
20. Rong F., Chow S., Yan S., Larson G., Hong Z., and Wu J. (2007), Structure-activity relationship (SAR) studies of quinoxalines as novel HCV NS5B RNA-depend-ent RNA polymerase inhibitors. Bioorg. Med. Chem. Lett. 17, 1663-1666.
21. Schiaffella F., Macchiarulo A., Milanese L., Vecchiarelli A., and Fringuelli R. (2006), Novel ketoconazole analogues based on the replacement of 2, 4-dichlorophe-nyl group with 1, 4-benzothiazine moiety: design, synthesis, and microbiological evaluation. Bioorg. Med. Chem. 14, 5196-5203.
22. Smith R., Krohn P. K., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., and Klenk D. C. (1992), Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-80.
23. Van Amsterdam F. T., Roveri A., Maiorino M., Ratti E., and Ursini F. (1992), Lacidipine: A dihydropyridine calcium antagonist with antioxidant activity. Free Rad. Biol. Med. 12, 183-187.